Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEV90 Study of Ropivacaine for Ultrasound-Guided Interscalene Muscle Fascial Block in Shoulder Arthroscopy
ChiCTR2400083266Phase 4Recruiting
- Sponsor
- Xi'an Honghui Hospital
- Start
- Apr 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ropivacaine in Rotator cuff deficiency (RCD), sponsored by Xi'an Honghui Hospital. Primary endpoint: MEV90 of ropivacaine. Started Apr 2024; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
Rotator cuff deficiency (RCD)
Beyond the preview
Go deeper on ChiCTR2400083266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083266.